Protective Effect and Mechanism of Apolipoprotein A-1 Mimetic Peptide L-4F on Atherosclerosis in Mice Model
YING Ru,YUAN Yong,QIN Ya-fei,FENG Li,TIAN Di,GUO Zhi-gang,LI Ming-xing
DOI: https://doi.org/10.3969/j.issn.1000-3614.2013.05.017
2013-01-01
Abstract:Objective: To observe the effects of apolipoprotein A-1(Apo-A1) mimetic peptide L-4F(L-4F) and simvastatin on cholesterol efflux and atherosclerosis in Apo E-/-mice model. Methods: 8 weeks male Apo E-/-mice were randomly divided into 3 groups, Atherosclerosis(AS) group, the mice were treated with high fat diet, Simvastatin group, high fat diet+simvastatin, and L-4F group, high fat diet+ L-4F. n=6 in each group. All animals were treated for 16 weeks, and then, serum lipid level was recorded, Apo-A1 concentration was examined by ELISA, aortic AS plaque was observed by red O oil staining, cholesterol efflux was evaluated by liquid scintillation spectrometry. The mRNA and protein expression of liver ABCA1, SR-BI and ABCG1were detected by RT-PCR and Western blot respectively. Results: ① Compared with AS group, Simvastatin group presented decreased levels of TC, TG, LDL-C and increased HDL-C, P<0.05~0.01, while L-4F group showed obviously increased Apo-A1 concentration, P<0.05. ② Compared with Simvastatin group and AS group, L-4F group had increased cholesterol efflux, P<0.001, compared with AS group, Simvastatin group also had increased cholesterol efflux, P<0.001. ③ Compared with AS group, the other 2 groups had smaller AS plaque area, P<0.001. ④ Compared with AS group, Simvastatin group presented increased protein expression of ABCA1 and ABCG1, P<0.001 and L-4F group showed increased protein expression of ABCA1, SR-BI and ABCG1, P<0.001. Conclusion: L-4F may promote cholesterol efflux by up-regulating ABCA1, SR-BI and ABCG1 expression in the liver, and therefore, attenuate the atherosclerosis in Apo E-/-mice model.